Seminar Series Schedule 2012
January 5, 2012 - 11:00 AM - Lale Bildirici-Ertekin, PhD (Kutztown University)
"The Use of Immunoporation for Efficient Cell Transfection"
January 12, 2012 - 11:00 AM - Yvonne Paterson, PhD (University of Pennsylvania School of Medicine)
"Cancer Immunotherapy With Listeria Vectors That Target the Tumor On All Fronts"
January 17, 2012 - 11:00 AM - David Newman, PhD (Natural Products Branch, Development Therapeutics Program, NCI)
"Natural Products: Still Viable As Drug Leads In The 21st Century?"
January 19, 2012 - 11:00 AM - Klaus Klumpp, PhD (Hoffmann-La Roche, Inc.)
"Antiviral Drug Discovery and Development: Converting Screening Hits Into Clinical Candidates"
January 26, 2012 - 4:00 PM - Michael J. Sofia, PhD* (Pharmasset, Inc.)
"Nucleotide Prodrugs for Treating HCV Infection: From Discovery to the Clinic"
February 2, 2012 - 11:00 AM - Robert Doms, MD, PhD (University of Pennsylvania School of Medicine)
"Reconstructing Berlin: Zinc-Finger Nucleases and HIV-1 Therapy"
February 16, 2012 - 11:00 AM - Frederic Bushman, PhD (University of Pennsylvania School of Medicine)
"The Human Microbiome in Health and Disease"
March 7, 2012 - 9:00-10:30 AM - Chris Molineaux (President, Pennsylvania Bio)
"PA Bio 2012 Outlook"
Reservations Required: Please email karen@pennsylvaniabio.org to RSVP
March 15, 2012 - 11:00 AM - Todd Schell, PhD (Pennsylvania State University College of Medicine)
"Targeting the Strong and the Weak: Recruiting CD8+ T Cells Against SV40 Large T Antigen"
March 29, 2012 - 4:00 PM - Joseph Aceto, PhD, Esq.*/**
"A Legal Primer for Scientists, Entrepreneurs, and Biotech Companies"
April 5, 2012 - 11:00 AM - Patrick Lam, PhD**
"Structure-Based Discovery of the Factor Xa Inhibitor, Eliquis (Apixaban), as a Novel Anticoagulant"
April 26, 2012 - 11:00 AM - Scott L. Diamond, PhD** (Institute for Medicine & Engineering, University of Pennsylvania)
"High Throughput Biotechnology"
April 27, 2012 - 4:00 PM - Howard K. Koh, MD, MPH (Assistant Secretary for Health, US Department of Health & Human Services)
"A National Strategy for the Prevention and Control of Viral Hepatitis"
Hepatitis B Foundation's 2012 Baruch S. Blumberg Prize
May 17, 2012 - 11:00 AM - George Trainor, PhD** (Trainor Consulting, LLC - formerly VP, BMS Chemistry)
"Chemical Principles of Drug Action In Vivo"
May 24, 2012 - 11:00 AM - Hydar Ali, PhD (University of Pennsylvania)
"Human Mast Cell and Humanized Mice for the Study of Host Defense and Allergic Asthma"
POSTPONED - Robert Lanford, PhD (Texas Biomedical Research Institute)
"The Chimpanzee Model of HCV and HBV Infections; Novel Therapeutics Based on MicroRNAs and Toll-Like Receptors"
Distinguished Lecturer Series
June 8, 2012 - 4:00 PM - Snorri S. Thorgeirsson, MD, PhD (Center for Cancer Research, National Cancer Institute, NIH)
"Deconstructing Liver Cancer: From Genome to Stem Cells"
Hepatitis B Foundation's 2012 Bruce Witte Lecturer
June 28, 2012 - 11:00 AM - Michael Nonnemacher, PhD (Drexel University College of Medicine)
"HIV-1 LTR Polymorphisms as Potential Markers for Peripheral and Neurologic Disease Progression"
July 10, 2012 - 4:00 PM - Jose Falconi* (VerdanTech LLC)
"Why Look to Latin America for Potential Business, and What's Essential to Know? (Brazil as Case Study)
July 12, 2012 - 11:00 AM - Mauricio Reginato, PhD (Drexel University College of Medicine)
"Targeting O-GlcNacylation: Taking the Sugar Out of Cancer"
July 17, 2012 - 11:00 AM - Patrick Loll, PhD (Drexel University College of Medicine)
"Killing Bad Guys With X-Rays: How Structure Can Inform Antibiotic Design"
July 19, 2012 - 11:00 AM - Anthony Ford-Hutchinson, PhD (Former Sr. VP, Vaccines Research & Development, Merck Research Laboratories)
"Challenges in the Discovery and Distribution of Novel Vaccines"
July 26, 2012 - 11:00 AM - Zhaoyu Li, PhD (University of Pennsylvania School of Medicine)
"Foxa in Liver Development and Cancer"
July 31, 2012 - 4:00 PM - Michael Poisel, MS, MBA & Heather Steinman, PhD, MBA* (UPstart, Center for Technology Transfer, University of Pennsylvania)
"UPstart: Incubating Innovation"
August 2, 2012 - 11:00 AM - Lisa Minor** (In Vitro Strategies, LLC)
"Reproducible and Quantitative Analysis of Cell Morphology and Subcellular Structures Through Controlling Cell Surface Adhesion-2D+"
August 17, 2012 - 11:00 AM - T. Rajendra Kumar, PhD (University of Kansas Medical Center)
"Genetics and Pathophysiology of Pituitary Null Cell Tumors"
August 30, 2012 - 11:00 AM - Michael Racke, MD (Wexner Medical Center at The Ohio State University)
"TBA"
September 13, 2012 - 11:00 AM - Robert Lanford, PhD (Texas Biomedical Research Institute)
"The Chimpanzee Model of HCV and HBV Infections: Novel Therapeutics Based on MicroRNAs and Toll-Like Receptors"
Distinguished Lecturer Series
October 12, 2012 - 8:30 AM - 1:00 PM - Annual Biotech Conference* - Regional Biotech Council
"TBA"
Watch For Information Regarding Registration
October 18, 2012 - 11:00 AM - Rodrigo Andrade, PhD** (Temple University)
"Adventures in Chemical Synthesis - Part I: Discovery of Novel Macrolide Antibiotics, Part II: Total Synthesis of Strychnos Alkaloids"
*Regional Biotech Council (RBC) Seminar Speakers (Registration may be required)
**Pennsylvania Drug Discovery Institute Seminar Speakers
